BellRock Brands Inc. has entered into a licensing agreement with Dark Horse Medicinals, LLC to bring Mary's Medicinals and Dixie Brands to Arkansas.

Mary's Medicinals products will be available in Arkansas in the fourth quarter of 2023, while the launch of Dixie products is expected to follow in 2024.

"Dark Horse is a cannabis leader in Arkansas,” said Brian Jansen, president and CEO of BellRock Brands. “They have a customer-first mentality as evidenced by their market penetration and loyal consumer following. We are excited to launch Mary's award-winning patches and wellness products this year.”

“Dark Horse Medicinals is proud to partner with BellRock Brands to bring Mary's Medicinals and Dixie to Arkansas patients,” added Dark Horse CEO Casey Flippo. “We firmly believe in bringing quality and consistent products to the people of Arkansas and BellRock has a proven track record of each of those core values.”

Additionally, Dixie Brands is launching several new product lines in Missouri under its licensing agreement with its strategic partner, BRB Missouri, LLC. Dixie Peak gummies, Dixie SYNERGY gummies and Dixie Vapes will all be available throughout Missouri by the end of 2023. Peak gummies will cater to the rapidly growing sub-category of high milligram products. SYNERGY gummies introduce ratioed and products containing minor cannabinoids. 

BellRock is also continuing to execute its previously announced operational turnaround. Last year, the company made changes to senior management and engaged West 4th Holdings, LLC, a management consulting firm focused on improving operational productivity for small to midsize companies. Under this leadership, BellRock continues to execute strategies to reduce costs, drive margin expansion and improve cash flow. 

Alongside these operational actions, BellRock has engaged creditors with the goal of lowering its overall debt and interest burden. In pursuing a long-term success strategy, BellRock is considering all strategic alternatives to maximize value for its various stakeholders. These may include, but are not limited to, future corporate development activities, restructuring of debt obligations on its balance sheet and raising new capital.